Spaull, RVV;
Soo, AKS;
Hogarth, P;
Hayflick, SJ;
Kurian, MA;
(2021)
Towards Precision Therapies for Inherited Disorders of Neurodegeneration with Brain Iron Accumulation.
Tremor and Other Hyperkinetic Movements
, 11
(1)
, Article 51. 10.5334/tohm.661.
Preview |
Text
Spaull_661-4629-1-PB.pdf Download (1MB) | Preview |
Abstract
Background: Neurodegeneration with brain iron accumulation (NBIA) disorders comprise a group of rare but devastating inherited neurological diseases with unifying features of progressive cognitive and motor decline, and increased iron deposition in the basal ganglia. Although at present there are no proven disease-modifying treatments, the severe nature of these monogenic disorders lends to consideration of personalized medicine strategies, including targeted gene therapy. In this review we summarize the progress and future direction towards precision therapies for NBIA disorders. / Methods: This review considered all relevant publications up to April 2021 using a systematic search strategy of PubMed and clinical trials databases. / Results: We review what is currently known about the underlying pathophysiology of NBIA disorders, common NBIA disease pathways, and how this knowledge has influenced current management strategies and clinical trial design. The safety profile, efficacy and clinical outcome of clinical studies are reviewed. Furthermore, the potential for future therapeutic approaches is also discussed. / Discussion: Therapeutic options in NBIAs remain very limited, with no proven disease-modifying treatments at present. However, a number of different approaches are currently under development with increasing focus on targeted precision therapies. Recent advances in the field give hope that novel strategies, such as gene therapy, gene editing and substrate replacement therapies are both scientifically and financially feasible for these conditions.
| Type: | Article |
|---|---|
| Title: | Towards Precision Therapies for Inherited Disorders of Neurodegeneration with Brain Iron Accumulation |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.5334/tohm.661 |
| Publisher version: | http://doi.org/10.5334/tohm.661 |
| Language: | English |
| Additional information: | This is an Open Access article published under a Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/). |
| Keywords: | NBIA, pantothenate kinase-associated neurodegeneration, PKAN, PLAN, MPAN, gene therapy |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10137795 |
Archive Staff Only
 |
View Item |
